Answers are grounded in this paper and cite their sources.
There is an emerging body of research demonstrating clear parallels between the biological mechanism of weight loss following bariatric surgery, and the pathophysiology of weight loss and malnutrition following esophagogastric cancer surgery. Recent evidence, both in the context bariatric surgery, and among patients following esophagogastric cancer surgery, identifies postoperative alterations in gut hormone signaling as an important mediator of weight loss. Indeed, gut hormone signaling may affect food intake through a number of distinct pathways, and as such gut hormones may represent as a potential pharmacologic target for the management of weight loss and malnutrition among patients following esophagogastric cancer surgery. This narrative review aims to provide the clinician caring for patients with esophagogastric cancer with an overview of the interplay between the homeostatic and hedonic pathways that are fundamental to the regulation of eating behavior, as well as how alterations to the secretory patterns of gut hormones after upper gastrointestinal surgery may influence these pathways causing weight loss. Several existing pharmacologic therapies that target aberrant gut-brain signaling, thus influencing eating behavior, are explored. A comprehensive understanding of how changes in the physiologic control of food intake postoperatively can manifest in altered eating behavior is essential in the clinical management of patients with weight loss and malnutrition following esophagogastric cancer surgery.
No takes yet. Share an insight, caveat, or question.
Stratford et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: